Details of the Drug Reposition

General Information of This Drug (ID: DMCN3UU)

Drug Name
EO2401   DMCN3UU
Drug Type
Vaccine

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Adrenocortical carcinoma DISZF4HX 2D11.Z Phase 1/2 [1]
Paraganglioma DIS2XXH5 2E92.2 Phase 1/2 [1]
Pheochromocytoma DIS56IFV 5A75 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04187404) A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma (Spencer). U.S. National Institutes of Health.